LeMaitre Vascular

LMAT

Market cap $1.9B

High coverage ratios and earnings growth make CAH, LTH, LMAT and FLS safer investment bets heading into 2026.

LeMaitre (LMAT) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:

The final trades of the day with CNBC's Melissa Lee and the 'Fast Money' traders.

BURLINGTON, Mass., Nov. 12, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will participate in three upcoming investor conferences.

LeMaitre (LMAT) is well positioned to outperform the market, as it exhibits above-average growth in financials.

LeMaitre Vascular, Inc. ( LMAT ) Q3 2025 Earnings Call November 6, 2025 5:00 PM EST Company Participants Dorian LeBlanc - Chief Financial Officer George LeMaitre - Chairman & CEO David Roberts - President & Director Conference Call Participants Michael Sarcone - Jefferies LLC, Research Division Shaymus Contorno - Oppenheimer & Co. Inc., Research Division Rick Wise Nathan Treybeck - Wells Fargo Securities, LLC, Research Division Michael Petusky - Barrington Research Associates, Inc., Research Division Brett Fishbin - KeyBanc Capital Markets Inc., Research Division James Sidoti - Sidoti & Company, LLC Kyle Bauser - ROTH Capital Partners, LLC, Research Division Daniel Stauder - Citizens JMP Securities, LLC, Research Division Presentation Operator Hello. Good day. This is RJ, your conference operator today, and we welcome you to the LeMaitre Vascular, Inc. Q3 2025 Financial Results Conference Call.

LeMaitre Vascular (LMAT) came out with quarterly earnings of $0.62 per share, beating the Zacks Consensus Estimate of $0.57 per share. This compares to earnings of $0.49 per share a year ago.

BURLINGTON, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q3 2025 results, announced a quarterly dividend of $0.20/share, and provided guidance.

Investors interested in stocks from the Medical - Products sector have probably already heard of Royal Philips (PHG) and LeMaitre Vascular (LMAT). But which of these two stocks presents investors with the better value opportunity right now?